Two Sigma Securities, LLC Alkermes Plc. Call Options Transaction History

Two Sigma Securities, LLC

6 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2023 Feb 14, 2024	BUY	$23.37 - $28.68 $189,297 - $232,308	8,100 New	8,100 $224,000
Q4 2022 Feb 14, 2023	SELL	$21.94 - $26.24 $94,342 - $112,832	-4,300 Reduced 22.16%	15,100 $394,000
Q3 2022 Nov 14, 2022	BUY	$22.0 - $31.87 $426,800 - $618,278	19,400 New	19,400 $433,000
Q4 2018 Feb 14, 2019	SELL	$27.94 - $44.61 $620,268 - $990,342	-22,200 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$38.6 - $46.12 $463,200 - $553,440	-12,000 Reduced 35.09%	22,200 $942,000
Q2 2018 Aug 14, 2018	BUY	$40.56 - $51.36 $1.39 Million - $1.76 Million	34,200 New	34,200 $1.41 Million

346

183M

209K

89.4K

Ticker ALKS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 164,254,000
Market Cap $4.54B
Description
Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...

Get notified when there are updates to the investment portfolio of Two Sigma Securities, LLC, based on Form 13F filings with the SEC.

Stay updated on Two Sigma Securities, LLC with notifications on news.